Vaxart Inc [VXRT] stock is trading at $0.99, up 8.71%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VXRT shares have gain 11.51% over the last week, with a monthly amount glided 66.88%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vaxart Inc [NASDAQ: VXRT] stock has seen the most recent analyst activity on August 15, 2024, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $4. On November 02, 2021, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $15 on the stock. B. Riley Securities downgraded its rating to a Neutral and decreased its price target to $9 on June 29, 2021. Jefferies initiated its recommendation with a Buy and recommended $13 as its price target on June 24, 2021. Piper Sandler started tracking with a Overweight rating for this stock on June 11, 2021, and assigned it a price target of $18. In a note dated August 12, 2020, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $7 to $17.
Vaxart Inc [VXRT] stock has fluctuated between $0.52 and $1.54 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Vaxart Inc [NASDAQ: VXRT] shares were valued at $0.99 at the most recent close of the market. An investor can expect a potential return of 102.02% based on the average VXRT price forecast.
Analyzing the VXRT fundamentals
Vaxart Inc [NASDAQ:VXRT] reported sales of 13.93M for the trailing twelve months, which represents a growth of 371.35%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -6.11%, Pretax Profit Margin comes in at -6.14%, and Net Profit Margin reading is -6.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.67, Equity is -1.14 and Total Capital is -0.77. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9305 points at the first support level, and at 0.8740 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0368, and for the 2nd resistance point, it is at 1.0866.
Ratios To Look Out For
For context, Vaxart Inc’s Current Ratio is 4.54. Also, the Quick Ratio is 4.54, while the Cash Ratio stands at 2.75. Considering the valuation of this stock, the price to sales ratio is 16.12, the price to book ratio is 2.81.
Transactions by insiders
Recent insider trading involved Watson W. Mark, Director, that happened on Jun 18 ’24 when 20000.0 shares were purchased.
